Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.55 USD
Change Today -0.08 / -2.20%
Volume 278.7K
EBIO On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Chen Schor MBA, CPA, BA, CPA

AgeTotal Calculated CompensationThis person is connected to 29 board members in 3 different organizations across 6 different industries.

See Board Relationships


Mr. Chen Schor, MBA, CPA, BA, CPA, has been the Chief Executive Officer and President of Synta Pharmaceuticals Corp. since May 7,2015 and served as its Chief Operating Officer and Executive Vice President from December 08, 2014 to May 7,2015. Mr. Schor served as the President and Chief Executive Officer at Novalere FP, Inc. He served as the Chief Business Officer of Eleven Biotherapeutics Inc. Mr. Schor joined Eleven Biotherapeutics on September 22, 2011. Mr. Schor has ...

Read Full Background

Corporate Headquarters*

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-871-9911
Fax: 617-858-0911

Board Members Memberships*

President, Chief Executive Officer, and Director
Chief Executive Officer, President and Director


Tel Aviv University
University of Haifa

Other Affiliations*

Annual Compensation*

Total Annual Compensation$77,516

Stock Options*

Restricted Stock Awards$427,500
Unexercisable Options450,000
Total Number of Options450,000

Total Compensation*

Total Annual Cash Compensation$77,516
Total Short Term Compensation$77,516
Other Long Term Compensation$427,500
Total Calculated Compensation$1,546,901
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBIO:US $3.55 USD -0.08


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELEVEN BIOTHERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at